Skip to main content
Equibles

MDMA · Pharmala Biotech Holdings Inc.

Use MDMA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDMA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.15 CAD -0.015 (-9.09%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked
Market Cap
16.53M CAD
Shares
110.18M
Volume · Nov 6 62.49K Avg daily vol (3M) 198.18K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close0.15 CAD Open0.175 CAD Day0.15–0.175 CAD 52W close0.09–0.325 CAD Avg vol 30d94K DataJan 2022–Nov 2026

Latest documents

2026
All documents

Quarterly results

Revenue Net income Net loss
· 57,297 CAD −479,109 CAD '25 Q1 LATEST ▲260.3% 206,440 CAD −409,695 CAD '26 Q1

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 0.09 CAD Now 0.15 CAD · 26% Range high 0.325 CAD
vs 200-day avg -4% vs 50-day avg -31%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XCNQ:MDMA -11.8% -28.6% +3.5% -11.8% +36.4%

Exchange listing

Market
XCNQ
Ticker
MDMA
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company

Website
https://pharmala.ca/

Other listings of this company

No other verified listings are available.

Latest price

Plus & Pro

Follow MDMA during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.